Physician profile
Morgan King
NPI 1386496776
$4,675.22
in general payments reported to CMS, 2019-2025
13 companies · $3,569 in 2025
The $3,569 reported for 2025 was more than what 98% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,106 · 2025: $3,569.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,838 · Travel and Lodging: $1,792 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,838.09 |
| Travel and Lodging | $1,792.13 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,528.28 | 2025 | Synchromedii, Intellis Adaptivestim |
| Abbott Laboratories | $1,235.66 | 2024-2025 | Proclaim, Eterna, Octrode |
| Nalu Medical, INC. | $887.20 | 2024-2025 | Nalu Neurostimulation System |
| Boston Scientific Corporation | $309.13 | 2025 | Wavewriter Alpha Prime 16 |
| Abbvie INC. | $124.98 | 2024 | |
| Kyowa Kirin, INC. | $123.16 | 2024 | |
| Axsome Therapeutics, INC. | $116.64 | 2025 | Auvelity |
| Eisai INC. | $84.38 | 2025 | |
| Corcept Therapeutics | $83.14 | 2025 | Korlym |
| Tonix Medicines, INC. | $69.69 | 2025 | Tonmya |
| Novo Nordisk INC | $61.47 | 2025 | Ozempic |
| Globus Medical, INC. | $33.52 | 2025 | Senza |
| Vertex Pharmaceuticals Incorporated | $17.97 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morgan King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.